Organovo Holdings, Inc.
ONVO
Peringkat dalam Saham
#35997
Organovo Holdings, Inc. is a biotechnology firm that specializes in engineering... Organovo Holdings, Inc. is a biotechnology firm that specializes in engineering sophisticated 3D tissues designed to accurately mimic critical facets of human diseases. Central to its operations is a comprehensive 3D human tissue platform, which features the company's proprietary NovoGen Bioprinters. These automated devices are crucial for fabricating complex, living 3D tissues from mammalian cells. The platform also includes supporting technologies necessary for creating specialized "bio-inks" and for the bioprinting of multi-cellular tissues with intricate structures. Organovo supplies specific products, such as ExVive human liver tissue and ExVive human kidney tissue, which are employed for predictive preclinical evaluation of investigational drug compounds. The company was founded in 2007 and maintains its corporate headquarters in Solana Beach, California.
Harga Saham
$2.00
Terakhir disinkronkan: 2025-05-19
Kapitalisasi Pasar
$2.93M
Perubahan (1 hari)
-3.38%
Perubahan (1 tahun)
656.14%
Negara
US
Perdagangan Organovo Holdings, Inc. (ONVO)
Kategori
Healthcare
Riwayat harga saham Organovo Holdings, Inc. (ONVO)
Harga penutupan tertinggi: $5.13 pada 2025-03-01
Harga penutupan terendah: $131.45 pada 2014-11-01
Harga penutupan terendah: $131.45 pada 2014-11-01
Riwayat harga saham Organovo Holdings, Inc. dari 2014 hingga 2026
Performa harga saham tahunan
| Tahun | Performa |
|---|---|
| 2025 | 6.61% |
| 2024 | -65.68% |
| 2023 | -24.35% |
| 2022 | -61.52% |
| 2021 | -70.29% |
| 2020 | -31.30% |
| 2019 | -29.19% |
| 2018 | 153.68% |
| 2014 | 0.00% |
Harga saham perusahaan atau pesaing serupa
| Perusahaan | Harga saham | Perubahan 1th% | Negara |
|---|---|---|---|
| $527.18 | 23.62% |
US
|
|
| $251.29 | 835.90% |
US
|
|
| $137.83 | -3.78% |
AU
|
|
| $890.85 | 9.42% |
NL
|
|
| $758.70 | 7.84% |
CH
|
